BeOne Medicines
Quarterly Financials
| Values in thousands | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
|---|---|---|---|---|
Revenue | $1,889,815 | $1,705,071 | $1,513,438 | $1,498,170 |
Gross Profit | 1,672,919 | 1,530,541 | 1,346,223 | 1,355,748 |
EBITDA | 452,767 | 392,713 | 333,246 | 248,971 |
EBIT | 452,767 | 352,198 | 292,102 | 212,987 |
Net Income | 384,706 | 237,007 | 227,357 | 66,502 |
Net Change In Cash | 1,889,815 | 1,705,071 | 1,513,438 | 1,498,170 |
Free Cash Flow | 473,532 | 595,891 | 161,025 | 131,275 |
Cash | 5,781,128 | 5,098,041 | 4,791,676 | 4,547,530 |
Basic Shares | 117,304 | 115,797 | 115,771 | 113,448 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $5,343,033 | $3,810,241 | $2,458,779 | $1,415,921 |
Gross Profit | 4,674,493 | 3,216,152 | 2,078,859 | 1,129,446 |
EBITDA | 616,774 | -361,239 | -738,161 | -1,894,759 |
EBIT | 475,088 | -533,001 | -825,836 | -1,961,037 |
Net Income | 286,933 | -644,786 | -881,708 | -2,003,815 |
Net Change In Cash | 5,343,033 | 3,810,241 | 2,458,779 | 1,415,921 |
Free Cash Flow | 941,741 | -669,768 | -1,753,714 | -1,965,718 |
Cash | 4,547,530 | 2,627,410 | 3,171,800 | 3,869,564 |
Basic Shares | 113,448 | 105,288 | 104,387 | 103,133 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-09-30 | $3.64 |
2026-06-30 | $2.05 |
2026-03-31 | $1.96 |
2025-12-31 | $0.58 |